Advertisement
Screener

ALPINE IMMUNE SCIENCES, INC. Investing Cash Flow

ALPINE IMMUNE SCIENCES, INC. Investing Cash Flow

ALPINE IMMUNE SCIENCES, INC. reported Investing Cash Flow of -$2.56 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.

Discontinued › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2024-05-09

  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2024-03-31 was -$2.56M, a 109.04% decline year-over-year.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was -$112.70M.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was -$535.00K, a 102.07% decline year-over-year.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) investing activities for the quarter ending 2023-06-30 was $29.33M, a 346.80% increase year-over-year.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$55.56M.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$113.35M.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2021 was -$52.48M.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) investing activities for fiscal 2020 was -$72.82M, a 534.40% decline from fiscal 2019.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 6 month as first filedNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2024-03-31-$2.56M
10-Q · filed 2024-05-09
-$115.26M
derived: sum of 2 quarters · filed 2024-05-09
-$115.80M
derived: sum of 3 quarters · filed 2024-05-09
-$86.47M
derived: sum of 4 quarters · filed 2024-05-09
2023-12-31-$112.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
-$113.24M
derived: sum of 2 quarters · filed 2024-03-20
-$83.91M
derived: sum of 3 quarters · filed 2024-03-20
-$55.56M
10-K · filed 2024-03-20
2023-09-30-$535.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$28.79M
derived: sum of 2 quarters · filed 2023-11-14
$57.14M
10-Q · filed 2023-11-14
-$50.76M
derived: sum of 4 quarters · filed 2024-05-09
2023-06-30$29.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$57.68M
10-Q · filed 2023-08-14
-$50.22M
derived: sum of 3 quarters · filed 2024-05-09
-$24.43M
derived: sum of 4 quarters · filed 2024-05-09
2023-03-31$28.35M
10-Q · filed 2024-05-09
-$79.55M
derived: sum of 2 quarters · filed 2024-05-09
-$53.76M
derived: sum of 3 quarters · filed 2024-05-09
-$47.20M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$107.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
-$82.11M
derived: sum of 2 quarters · filed 2024-03-20
-$75.55M
derived: sum of 3 quarters · filed 2024-03-20
-$113.35M
10-K · filed 2024-03-20
2022-09-30$25.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$32.35M
derived: sum of 2 quarters · filed 2023-11-14
-$5.45M
10-Q · filed 2023-11-14
-$9.73M
derived: sum of 4 quarters · filed 2024-03-20
2022-06-30$6.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$31.24M
10-Q · filed 2023-08-14
-$35.52M
derived: sum of 3 quarters · filed 2024-03-20
-$98.04M
derived: sum of 4 quarters · filed 2024-03-20
2022-03-31-$37.80M
10-Q · filed 2023-05-11
-$42.09M
derived: sum of 2 quarters · filed 2024-03-20
-$104.60M
derived: sum of 3 quarters · filed 2024-03-20
-$83.74M
derived: sum of 4 quarters · filed 2024-03-20
2021-12-31-$4.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
-$66.80M
derived: sum of 2 quarters · filed 2024-03-20
-$45.93M
derived: sum of 3 quarters · filed 2024-03-20
-$52.48M
10-K · filed 2024-03-20
2021-09-30-$62.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$41.65M
derived: sum of 2 quarters · filed 2022-11-14
-$48.20M
10-Q · filed 2022-11-14
-$145.04M
derived: sum of 4 quarters · filed 2023-03-23
2021-06-30$20.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$14.32M
10-Q · filed 2022-08-11
-$82.53M
derived: sum of 3 quarters · filed 2023-03-23
-$80.69M
derived: sum of 4 quarters · filed 2023-03-23
2021-03-31-$6.55M
10-Q · filed 2022-05-12
-$103.39M
derived: sum of 2 quarters · filed 2023-03-23
-$101.55M
derived: sum of 3 quarters · filed 2023-03-23
-$92.50M
derived: sum of 4 quarters · filed 2023-03-23
2020-12-31-$96.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
-$95.01M
derived: sum of 2 quarters · filed 2023-03-23
-$85.95M
derived: sum of 3 quarters · filed 2023-03-23
-$72.82M
10-K · filed 2023-03-23
2020-09-30$1.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$10.90M
derived: sum of 2 quarters · filed 2021-11-10
$24.03M
10-Q · filed 2021-11-10
$28.42M
derived: sum of 4 quarters · filed 2022-03-17
2020-06-30$9.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
$22.19M
10-Q · filed 2021-08-10
$26.57M
derived: sum of 3 quarters · filed 2022-03-17
$37.44M
derived: sum of 4 quarters · filed 2022-03-17
2020-03-31$13.13M
10-Q · filed 2021-05-13
$17.52M
derived: sum of 2 quarters · filed 2022-03-17
$28.38M
derived: sum of 3 quarters · filed 2022-03-17
$10.79M
derived: sum of 4 quarters · filed 2022-03-17
2019-12-31$4.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
$15.25M
derived: sum of 2 quarters · filed 2022-03-17
-$2.34M
derived: sum of 3 quarters · filed 2022-03-17
$16.76M
10-K · filed 2022-03-17
2019-09-30$10.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
-$6.72M
derived: sum of 2 quarters · filed 2020-11-12
$12.38M
10-Q · filed 2020-11-12
$21.51M
derived: sum of 4 quarters · filed 2021-03-18
2019-06-30-$17.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
$1.51M
10-Q · filed 2020-08-11
$10.65M
derived: sum of 3 quarters · filed 2021-03-18
$26.42M
derived: sum of 4 quarters · filed 2021-03-18
2019-03-31$19.10M
10-Q · filed 2020-05-14
$28.23M
derived: sum of 2 quarters · filed 2021-03-18
$44.01M
derived: sum of 3 quarters · filed 2021-03-18
$47.35M
derived: sum of 4 quarters · filed 2021-03-18
2018-12-31$9.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
$24.91M
derived: sum of 2 quarters · filed 2021-03-18
$28.25M
derived: sum of 3 quarters · filed 2021-03-18
$32.12M
10-K · filed 2021-03-18
2018-09-30$15.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$19.11M
derived: sum of 2 quarters · filed 2019-11-14
$22.98M
10-Q · filed 2019-11-14
$24.84M
derived: sum of 4 quarters · filed 2020-03-30
2018-06-30$3.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
$7.21M
10-Q · filed 2019-08-13
$9.06M
derived: sum of 3 quarters · filed 2020-03-30
-$22.37M
derived: sum of 4 quarters · filed 2020-03-30
2018-03-31$3.87M
10-Q · filed 2019-05-09
$5.72M
derived: sum of 2 quarters · filed 2020-03-30
-$25.71M
derived: sum of 3 quarters · filed 2020-03-30
-$25.82M
derived: sum of 4 quarters · filed 2020-03-30
2017-12-31$1.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
-$29.58M
derived: sum of 2 quarters · filed 2020-03-30
-$29.70M
derived: sum of 3 quarters · filed 2020-03-30
-$29.80M
10-K · filed 2020-03-30
2017-09-30-$31.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$31.55M
derived: sum of 2 quarters · filed 2018-11-08
-$31.66M
10-Q · filed 2018-11-08
-$31.98M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30-$113.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$221.00K
10-Q · filed 2018-08-09
$14.97M
10-Q · filed 2017-07-21
-$544.00K
derived: sum of 3 quarters · filed 2019-03-18
-$4.89M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31-$108.00K
10-Q · filed 2018-05-14
-$431.00K
derived: sum of 2 quarters · filed 2019-03-18
-$4.78M
derived: sum of 3 quarters · filed 2019-03-18
2016-12-31-$323.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
-$4.67M
derived: sum of 2 quarters · filed 2019-03-18
-$782.00K
10-K · filed 2019-03-18
2016-09-30-$4.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
-$459.00K
10-Q · filed 2017-11-14
2016-06-30$3.89M
10-Q · filed 2017-07-21
2015-12-31-$7.00K
10-K · filed 2018-03-28